CCL2 and cerebrovascular disorder: For instance, C‐C motif chemokine ligand 2/monocyte‐chemoattractant protein‐1 (CCL2/MCP1) is known to substantially increase after diverse cerebrovascular diseases including ischemic stroke, and its levels even positively correlate with detrimental patients' outcome (Geng et al, 2022).